Monotherapy vs. Combination Therapy
Compare monotherapy versus combination therapy in treating drug-resistant malaria: learn why using multiple drugs simultaneously reduces the chance of resistance developing in pathogen populations.
Key Concepts
To combat resistance, engineers analyze probability. Monotherapy relies on a single drug. If a parasite has a mutation that resists that one drug, it survives and resistance spreads quickly.
Combination therapy uses two or more drugs with different mechanisms of action simultaneously. For a parasite to survive, it would need to possess specific mutations for both drugs at the exact same time. The probability of this double mutation occurring randomly is extremely low.
Common Questions
What is the difference between monotherapy and combination therapy?
Monotherapy uses one drug to treat an infection; combination therapy uses two or more drugs together. Combination therapy is more effective against resistant pathogens because resistance to multiple drugs simultaneously is far less likely.
Why does combination therapy reduce antibiotic or drug resistance?
For a pathogen to survive combination therapy, it must develop resistance to all drugs at once — an extremely rare event. Monotherapy requires only one mutation, making resistance much easier to evolve.
How does this apply to treating drug-resistant malaria in Grade 8?
Grade 8 students study artemisinin-based combination therapies as a model of how combining drugs with different mechanisms of action creates a more robust treatment resistant to evolutionary escape.